Raúl De Lucas, Dr.

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

• Primary hyperoxaluria type 3→

Clinical trials (1)

• NCT04287777

Verify independently

• ClinicalTrials.gov PI search for Raúl De Lucas, Dr.

Other specialists for Primary hyperoxaluria type 3

Peers ranked by clinical-trial PI role, publications, and verification quality.

• Dawn Milliner, MD, M.D
  Mayo Clinic
  MN
• Verity Rawson
  Dicerna, A Novo Nordisk Company
• Verity Rawson, MB.CHB
  Dicerna, A Novo Nordisk Company
  California
• Robert Maki, MD, PhD, MD, PhD
  Memorial Sloan Kettering Cancer Center
  PA
• John C Lieske, M.D., M.D
  Mayo Clinic
  MN
• Sarb Shergill, PhD
  Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
• John Lieske, MD, M.D
  Mayo Clinic
  MN
• Alexandra Haagensen, MD, MBA, MD
  Dicerna Pharmaceuticals
  MA

See all specialists for Primary hyperoxaluria type 3 →